シングルセル解析の市場規模、シェア、成長分析、製品別、細胞の種類別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

シングルセル解析の世界市場規模は、2023年に43億4,000万米ドルと評価され、2024年の51億5,000万米ドルから2032年には203億米ドルに成長し、予測期間（2025-2032年）のCAGRは18.7％で成長する見通しです。

シングルセル解析市場は、創薬、疾患スクリーニング、がん罹患率の増加などにおける多様なアプリケーションによって大きな成長を遂げています。シークエンシング技術の進歩により、単一細胞の解析および分離機能が強化され、個々の細胞のトランスクリプトームおよびゲノムの精密な検査が可能になりました。この詳細な解析により、生理学的変化に対するユニークな細胞応答が明らかになり、様々な系統や機能が明らかになりました。この技術の急速な進化は、Clinicaltrials.govに報告されているように、22の第II相臨床研究への応用で明らかです。シングルセル解析は、今や生物学的複雑性を理解する上で極めて重要であり、免疫学やその他の分野にも拡大しています。最新のシークエンシングは、1回の実験で数千から数百万の細胞の解析を可能にし、診断や研究に十分な機会を生み出し、市場の成長を促進しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 貿易分析

シングルセル解析市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 消耗品
  • 試薬とキット
  • マイクロプレート
  • ビーズ
  • スライド
  • その他の消耗品
• 機器
  • フローサイトメーター
  • 次世代シーケンシング（NGS）プラットフォーム
  • ポリメラーゼ連鎖反応（PCR）装置
  • 顕微鏡
  • マスサイトメーター
  • その他
• ソフトウェアとサービス
  • データ分析ソフトウェア
  • イメージングソフトウェア
  • シーケンスデータ解釈ツール
  • カスタムサービス

シングルセル解析市場規模：細胞の種類別& CAGR（2025-2032）

• 市場概要
• ヒト細胞
• 動物細胞
• 微生物細胞
• 植物細胞

シングルセル解析市場規模：技術別& CAGR（2025-2032）

• 市場概要
• フローサイトメトリー
• 次世代シーケンシング
• 定量PCR
• 顕微鏡ベースの技術
• その他

シングルセル解析市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 調査アプリケーション
  • ゲノミクス
  • トランスクリプトミクス
  • プロテオミクス
  • エピゲノミクス
  • メタボロミクス
• 臨床応用
  • がん
  • 免疫学
  • 神経学
  • 感染症
  • 出生前診断
  • 希少疾患の検出
• 幹細胞調査
• 医薬品の発見と開発
• その他

シングルセル解析市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 学術調査機関
• 製薬・バイオテクノロジー企業
• 病院および診断検査室
• 契約調査機関（CRO）
• 政府および規制機関

シングルセル解析市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Danaher Corporation-USA
• Thermo Fisher Scientific Inc.-USA
• Merck KGaA-Germany
• 10x Genomics-USA
• BD（Becton, Dickinson and Company）-USA
• QIAGEN-Netherlands
• CYTENA GmbH-Germany
• Sartorius AG-Germany
• Tecan Trading AG-Switzerland
• Takara Bio Inc.-Japan
• BIOMERIEUX-France
• Agilent Technologies, Inc.-USA
• Standard BioTools-USA
• Bio-Rad Laboratories, Inc.-USA
• Illumina, Inc.-USA
• RareCyte, Inc.-USA
• On-chip Biotechnologies Co., Ltd-Japan
• Oxford Nanopore Technologies plc-UK
• BGI-China
• Novogene Co., Ltd-China

結論と提言

Global Single Cell Analysis Market size was valued at USD 4.34 billion in 2023 and is poised to grow from USD 5.15 billion in 2024 to USD 20.3 billion by 2032, growing at a CAGR of 18.7% during the forecast period (2025-2032).

The Single Cell Analysis Market is experiencing significant growth driven by its diverse applications in drug discovery, disease screening, and the increasing prevalence of cancer. Advances in sequencing technology have enhanced single-cell analysis and isolation capabilities, enabling precise examination of individual cell transcriptomes and genomes. This detailed analysis uncovers unique cellular responses to physiological changes, revealing various lineages and functions. The technology's rapid evolution is evident, with its application in 22 phase-II clinical studies, as reported on Clinicaltrials.gov. Single-cell analysis is now crucial for understanding biological complexity, expanding into immunology and other fields. Modern sequencing allows for the analysis of thousands to millions of cells in one experiment, creating ample opportunities for diagnostics and research, thereby propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Cell Analysis Market Segments Analysis

Global Single Cell Analysis Market is segmented by Product, Cell Type, Technique, Application, By End User and region. Based on Product, the market is segmented into Consumables, Instruments and Software & Services. Based on Cell Type, the market is segmented into Human Cells, Animal Cells, Microbial Cells and Plant Cells. Based on Technique, the market is segmented into Flow Cytometry, Next-Generation Sequencing, Quantitative PCR, Microscopy-based Techniques and Others. Based on Application, the market is segmented into Research Applications, Clinical Applications, Stem Cell Research, Drug Discovery & Development and Others. Based on By End User, the market is segmented into Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations (CROs) and Government & Regulatory Bodies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Single Cell Analysis Market

Recent advancements in mass cytometry and next-generation sequencing (NGS) have significantly improved the precision and detail of single-cell analysis techniques. These innovations allow researchers to gather comprehensive data on individual cells, paving the way for enhanced studies in immunology and cancer research. As a result, there has been a remarkable surge in demand for single-cell analytic technologies, driving the rapid growth of the Single Cell Analysis Market and attracting increased funding for research and development. This momentum highlights the crucial role of cutting-edge tools in advancing our understanding of complex biological systems and disease mechanisms.

Restraints in the Global Single Cell Analysis Market

One of the primary challenges facing the global single-cell analysis market is the substantial cost associated with advanced technologies and machinery. High-throughput sequencing systems and various single-cell analysis tools necessitate significant initial investments, which can be prohibitively expensive for many smaller laboratories and research institutions. This financial barrier can hinder their ability to acquire cutting-edge single-cell analysis equipment, ultimately limiting their capacity to engage in innovative research. As a result, the high costs associated with these technologies pose a significant constraint on the growth and expansion of the overall single-cell analysis market, making accessibility more difficult.

Market Trends of the Global Single Cell Analysis Market

The Global Single Cell Analysis market is witnessing a transformative trend with the integration of artificial intelligence (AI) and machine learning. These advanced technologies are revolutionizing the processing of complex data sets generated from single-cell experiments, enhancing data interpretation and enabling researchers to uncover significant biological insights with greater efficiency. By automating data pattern recognition, AI expedites the discovery process for scientists, illuminating cellular activities and disease mechanisms in unprecedented ways. As a result, the market is set to expand rapidly, driven by increased demand for innovative solutions that combine cutting-edge analytics with single-cell technologies, ultimately fostering advancements in personalized medicine and genomics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Trade Analysis

Global Single Cell Analysis Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
  • Reagents & Kits
  • Microplates
  • Beads
  • Slides
  • Other Consumables
• Instruments
  • Flow Cytometers
  • Next-Generation Sequencing (NGS) Platforms
  • Polymerase Chain Reaction (PCR) Instruments
  • Microscopes
  • Mass Cytometers
  • Others
• Software & Services
  • Data Analysis Software
  • Imaging Software
  • Sequencing Data Interpretation Tools
  • Custom Services

Global Single Cell Analysis Market Size by Cell Type & CAGR (2025-2032)

• Market Overview
• Human Cells
• Animal Cells
• Microbial Cells
• Plant Cells

Global Single Cell Analysis Market Size by Technique & CAGR (2025-2032)

• Market Overview
• Flow Cytometry
• Next-Generation Sequencing
• Quantitative PCR
• Microscopy-based Techniques
• Others

Global Single Cell Analysis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research Applications
  • Genomics
  • Transcriptomics
  • Proteomics
  • Epigenomics
  • Metabolomics
• Clinical Applications
  • Cancer
  • Immunology
  • Neurology
  • Infectious Diseases
  • Prenatal Diagnosis
  • Rare Disease Detection
• Stem Cell Research
• Drug Discovery & Development
• Others

Global Single Cell Analysis Market Size by By End User & CAGR (2025-2032)

• Market Overview
• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Contract Research Organizations (CROs)
• Government & Regulatory Bodies

Global Single Cell Analysis Market Size & CAGR (2025-2032)

• North America (Product, Cell Type, Technique, Application, By End User)
  • US
  • Canada
• Europe (Product, Cell Type, Technique, Application, By End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Technique, Application, By End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Technique, Application, By End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Technique, Application, By End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Danaher Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN - Netherlands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CYTENA GmbH - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Trading AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOMERIEUX - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RareCyte, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• On-chip Biotechnologies Co., Ltd - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI - China
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd - China
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations